Acebrophylline (Sustained Release) with Desloratadine & Montelukast Sodium Tablets – Breathe Better with All-Day Relief Through Triple-Action Therapy.
FOXIBRO dm: The combination of Acebrophylline 200mg + Desloratadine 5mg + Montelukast 10mg(Sustained Release) provides a synergistic treatment approach for managing chronic respiratory and allergic disorders. Acebrophylline (SR): Delivers long-lasting bronchodilation and anti-inflammatory benefits by relaxing airway muscles and regulating inflammatory mediators. Desloratadine: A potent antihistamine that relieves allergy symptoms such as sneezing, runny nose, and nasal blockage.Montelukast: A leukotriene receptor blocker that prevents airway inflammation and bronchospasm, improving breathing comfort.
Recommended By Specialists
✅Pulmonologists – for managing asthma, COPD, and allergy-related respiratory conditions.
✅General Physicians – for the routine management of allergic bronchitis and mild asthma.
✅Immunologists – for treating chronic respiratory allergies with immune involvement.
Key benefits of Acebrophylline (Sustained Release) with Desloratadine & Montelukast Sodium Tablets – FOXIBRO DM:
✅Triple-Mechanism Relief: Combines bronchodilator, anti-inflammatory, and antihistaminic effects to provide complete respiratory care.
✅Advanced Bilayered Technology: It offers a sustained release of Acebrophylline with the immediate action of Desloratadine and montelukast, ensuring quick and prolonged efficacy.
✅Allergen & Inflammation Control: Minimizes allergic triggers, reduces airway inflammation, and supports better lung function.
Indications
✅Allergic rhinitis accompanied by asthma
✅Chronic obstructive pulmonary disease (COPD) with allergic components
✅Bronchial asthma is associated with environmental or allergic triggers